does bpc 157 affect liver Frontiers Protecting and Repairing the Body

A literature and patent review published in Pharmaceuticals (MDPI) summarizes that BPC-157 demonstrates a desirable safety profile in preclinical research, with only a few side effects reported across animal studies, and documents its broad activity across tissue injury, inflammatory and CNS-adjacent research models via VEGFR2-Akt-eNOS angiogenic pathways and nitric oxide signaling

They made it very easy to use, even for beginners

GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is a naturally occurring tripeptide - three amino acids bound to a copper ion

At this time: Long term safety data is not available Human dosage guidelines are not established Side effects are not fully documented Use remains research based It should not be used casually or without medical supervision